Service Details

Summary Documents and Plans

We create key summary documents that present a clear, comprehensive overview of your clinical trial data for regulatory authorities and stakeholders. This includes clinical overviews, summaries, and regulatory strategy documents that offer concise interpretations of your research. We also develop Clinical Development Plans (CDP) and Target Product Profiles (TPP), serving as strategic roadmaps to align your product development with regulatory and clinical objectives.

  • 01 Project Management Plan

    Project Management Plan: A comprehensive document that outlines the strategy, processes, and guidelines for managing a project from initiation to completion. It serves as a roadmap for achieving project objectives, ensuring that the project is completed on time, within budget, and to the required quality standards.

  • 02 Clinical Validation Plan/Clin…

    Clinical Validation Plan/Clinical Performance Plan: Designed to confirm that a drug, device, or diagnostic test performs as intended in a real-world clinical setting. This plan is crucial for demonstrating the clinical utility and accuracy of the product.

  • 03 Performance Evaluation Plan (…

    Performance Evaluation Plan (PEP): Outlines the methodology for assessing the effectiveness and efficiency of a drug, medical device, or intervention within a clinical setting. This plan ensures that the product meets predefined performance criteria and regulatory standards

  • 04 Risk Management Plan (RMP)

    Risk Management Plan (RMP): Document used in clinical trials and pharmaceutical development to identify, assess, and mitigate risks associated with a drug or intervention. It outlines strategies to manage potential risks to ensure patient safety, maintain product quality, and meet regulatory requirements.

  • 05 Patient safety narratives

    Patient safety narratives: Patient safety narratives are detailed and structured accounts of individual patient experiences related to adverse events or safety issues observed during clinical trials or in real-world settings